Order Article Reprints

Anwar S, Tan W, Hong C-C, Admane S, Dozier A, Siedlecki F, Whitworth A, DiRaddo AM, DePaolo D, Jacob SM, et al. Quality-of-Life (QOL) during Screening for Phase 1 Trial Studies in Patients with Advanced Solid Tumors and Its Impact on Risk for Serious Adverse Events. Cancers. 2017; 9(7):73. https://doi.org/10.3390/cancers9070073

Anwar, Sidra, Wei Tan, Chi-Chen Hong, Sonal Admane, Askia Dozier, Francine Siedlecki, Amy Whitworth, Ann Marie DiRaddo, Dawn DePaolo, Sandra M. Jacob, and et al. 2017. "Quality-of-Life (QOL) during Screening for Phase 1 Trial Studies in Patients with Advanced Solid Tumors and Its Impact on Risk for Serious Adverse Events" Cancers 9, no. 7: 73. https://doi.org/10.3390/cancers9070073

Anwar, S., Tan, W., Hong, C.-C., Admane, S., Dozier, A., Siedlecki, F., Whitworth, A., DiRaddo, A. M., DePaolo, D., Jacob, S. M., Ma, W. W., Miller, A., Adjei, A. A., & Dy, G. K. (2017). Quality-of-Life (QOL) during Screening for Phase 1 Trial Studies in Patients with Advanced Solid Tumors and Its Impact on Risk for Serious Adverse Events. Cancers, 9(7), 73. https://doi.org/10.3390/cancers9070073